IRIDEX Corp. demonstrated a strong finish to 2025, marked by accelerating revenue growth, positive cash flow in the fourth quarter, and an expected positive adjusted EBITDA for the full year. The company attributes these improvements to focused cost reductions, gross margin expansion, and enhanced commercial efficiency, particularly in probe sales.
Fourth quarter total revenue expected to be between $14.6 million and $14.8 million, representing year-over-year growth between 15% and 17%.
positiveAchieved positive cash flow in the fourth quarter of 2025.
positiveFull year 2025 total revenue expected to be between $52.5 million and $52.7 million, representing year-over-year growth of 8%.
positiveCompany expects to achieve positive adjusted EBITDA for the full year 2025.
positiveSold 15,800 Cyclo G6® probes in Q4 2025, compared to 13,300 in the prior year quarter.
positiveSold 57,700 Cyclo G6® probes for the full year 2025, compared to 55,400 in the prior year.
positiveSold 44 Cyclo G6 Glaucoma Laser Systems in Q4 2025, compared to 47 in the prior year quarter, indicating a slight decline in system sales.
attentionSold 133 Cyclo G6 Glaucoma Laser Systems for the full year 2025, compared to 125 in the prior year, showing modest growth in system sales.
attentionMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
| Segment | Current | Prior Yr | YoY | % Total |
|---|---|---|---|---|
Glaucoma | N/A | — | — | — |
| Total Revenue | $0.00M | — | — | 100.0% |
Segment performance shows business unit health and growth drivers.
Strengthened our financial position through focused cost reductions, gross margin expansion, and improved commercial efficiency, and increased probe sales.
In 2025 we delivered on our goals, driving a fifth consecutive quarter of year-over-year revenue growth, reduced operating expenses, and improved adjusted EBITDA.
Achieved positive cash flow in the fourth quarter of 2025, and we expect to achieve positive adjusted EBITDA for the full year 2025.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.